Tamsulosin hydrochloride
SIGMA/T1330 - ≥98% (HPLC)
Synonym: 5-
CAS Number: 106463-17-6
Empirical Formula (Hill Notation): C20H28N2O5S · HCl
Molecular Weight: 444.97
MDL Number: MFCD00922997
Linear Formula: C20H28N2O5S · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C20H28N2O5S.ClH/c1-4-2 |
| InChI key | ZZIZZTHXZRDOFM-XFULWGLBSA |
| originator | Boehringer Ingelheim |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CCOc1ccccc1OCCN[C@H](C |
| solubility | DMSO: >10 mg/mL |
| storage condition | desiccated |
| storage temp. | room temp |
| Biochem/physiol Actions: | Tamsulosin is a α1A/1D-adrenoceptor antagonist; Used as a treatment of BPH (benign prostatic hypertrophy). |
| Biochem/physiol Actions: | Tamsulosin is an α1A/1D-adrenoceptor antagonist used as a treatment of benign prostatic hypertrophy (BPH). Its activity as an ? blocker also affects the iris, and has led to complications during cataract surgery, a condition called "floppy iris" syndrome. |
| Features and Benefits: | This compound was developed by Boehringer Ingelheim . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


